Related Experiment Video
Updated: Aug 10, 2025

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
A case of malignant peritoneal mesothelioma with a Fitz-Hugh-Curtis syndrome-like imaging finding
Takanobu Iwadare1,2, Takefumi Kimura3,4, Yusuke Nagata2
1Department of Medicine, Division of Gastroenterology and Hepatology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Abstract:
Malignant peritoneal mesothelioma (MPeM) is a rare disease with a poor prognosis that develops in the mesothelial cells of the peritoneum. We encountered a 48-year-old man with no prior asbestos exposure who visited our hospital with abdominal pain. Laboratory findings showed elevated C-reactive protein of 15.5 mg/dL. Contrast-enhanced computed tomography (CT) detected a Fitz-Hugh-Curtis syndrome-like contrast effect on the liver surface and thickening of the peritoneum. Blood culture, Mycobacterium tuberculosis-specific IFN-γ release assay, Chlamydia trachomatis and Neisseria gonorrhoeae DNA testing, and antinuclear antibody were all negative. CA125 was high at 124.8 U/mL. The laparoscopy for diagnostic purposes revealed adhesions between the liver surface and peritoneum in addition to numerous small and large white nodules on the peritoneum. Biopsy of the nodules confirmed the diagnosis of epithelial-type MPeM. Treatment was initiated with combined cisplatin and pemetrexed, and CT 6 months later showed a reduced contrast effect on the liver surface and improved peritoneal thickening. A Fitz-Hugh-Curtis syndrome-like contrast effect on the liver surface on contrast-enhanced CT may help identify MPeM.
Insights
Malignant peritoneal mesothelioma (MPeM), a rare cancer, can present with a Fitz-Hugh-Curtis syndrome-like liver surface effect on CT scans. This imaging finding may aid in diagnosing MPeM, even without asbestos exposure.
Area of Science:
- Oncology
- Radiology
- Pathology
Background:
- Malignant peritoneal mesothelioma (MPeM) is a rare neoplasm originating in the peritoneum.
- It typically has a poor prognosis and is often associated with asbestos exposure.
Observation:
- A 48-year-old male presented with abdominal pain and elevated CA125.
- Contrast-enhanced CT revealed a Fitz-Hugh-Curtis syndrome-like liver surface enhancement and peritoneal thickening.
- Laparoscopy showed peritoneal nodules and adhesions.
Findings:
- Biopsy confirmed epithelial-type malignant peritoneal mesothelioma.
- Treatment with cisplatin and pemetrexed led to improved imaging findings.
- The study highlights a potential imaging biomarker for MPeM.
Implications:
- A Fitz-Hugh-Curtis syndrome-like liver surface enhancement on CT may be an indicator for MPeM.
- This finding could assist in the early diagnosis of MPeM, particularly in cases without a history of asbestos exposure.
- Further research is warranted to validate this imaging sign in MPeM diagnosis.
More Related Videos
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024